» Articles » PMID: 15869932

Oxidative Stress and Inflammation in Parkinson's Disease: is There a Causal Link?

Overview
Journal Exp Neurol
Specialty Neurology
Date 2005 May 5
PMID 15869932
Citations 177
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by a dramatic loss of dopaminergic neurons in the substantia nigra (SN). Among the many pathogenic mechanisms thought to contribute to the demise of these cells, dopamine-dependent oxidative stress has classically taken center stage due to extensive experimental evidence showing that dopamine-derived reactive oxygen species and oxidized dopamine metabolites are toxic to nigral neurons. In recent years, however, the involvement of neuro-inflammatory processes in nigral degeneration has gained increasing attention. Not only have activated microglia and increased levels of inflammatory mediators been detected in the striatum of deceased PD patients, but a large body of animal studies points to a contributory role of inflammation in dopaminergic cell loss. Recently, postmortem examination of human subjects exposed to the parkinsonism-inducing toxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), revealed the presence of activated microglia decades after drug exposure, suggesting that even a brief pathogenic insult can induce an ongoing inflammatory response. Perhaps not surprisingly, non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce the risk of developing PD. In the past few years, various pathways have come to light that could link dopamine-dependent oxidative stress and microglial activation, finally ascribing a pathogenic trigger to the chronic inflammatory response characteristic of PD.

Citing Articles

The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic Source.

Jannat K, Balakrishnan R, Han J, Yu Y, Kim G, Choi D Cells. 2023; 12(22).

PMID: 37998387 PMC: 10670678. DOI: 10.3390/cells12222652.


A Promising Drug Candidate as Potent Therapeutic Approach for Neuroinflammation and Its In Silico Justification of Chalcone Congeners: a Comprehensive Review.

Karati D, Mukherjee S, Roy S Mol Neurobiol. 2023; 61(4):1873-1891.

PMID: 37801205 DOI: 10.1007/s12035-023-03632-0.


The Therapeutic Potential of Novel Carnosine Formulations: Perspectives for Drug Development.

Bonaccorso A, Privitera A, Grasso M, Salamone S, Carbone C, Pignatello R Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375726 PMC: 10300694. DOI: 10.3390/ph16060778.


The Transcription Factor Nrf2 Mediates the Effects of Extract on Neuropathological Changes in a Mouse Model of Parkinson's Disease.

Lanza M, Cucinotta L, Casili G, Filippone A, Basilotta R, Capra A Int J Mol Sci. 2023; 24(11).

PMID: 37298200 PMC: 10252478. DOI: 10.3390/ijms24119250.


Carotenoids: Role in Neurodegenerative Diseases Remediation.

Gandla K, Babu A, Unnisa A, Sharma I, Singh L, Haque M Brain Sci. 2023; 13(3).

PMID: 36979267 PMC: 10046158. DOI: 10.3390/brainsci13030457.